ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

33,382Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 5176

$2.24M Total Retail Price of All Prescriptions

Rank: 38 out of 5176

1,268 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 1,268 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

15% of this provider’s 1,268 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 28,942 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
FUROSEMIDE 1,110 1,005 1 8
LEVOTHYROXINE SODIUM 1,091 935 2 4
OMEPRAZOLE 1,065 860 3 3
SIMVASTATIN 869 779 4 1
AMLODIPINE BESYLATE 860 794 5 2
LISINOPRIL 831 723 6 5
ATENOLOL 756 703 7 12
METOPROLOL SUCCINATE 742 667 8 11
HYDROCODONE-ACETAMINOPHEN 673 552 S3 9 27
METFORMIN HCL 574 488 10 7
METOPROLOL TARTRATE 536 491 11 6
BUMETANIDE 495 440 12 209
WARFARIN SODIUM 483 420 13 13
ALENDRONATE SODIUM 477 432 14 18
CRESTOR 466 390 15 15
KLOR-CON 10 448 439 10 16 225
POTASSIUM CHLORIDE 429 377 17 34
FAMOTIDINE 412 379 18 58
KLOR-CON M20 401 340 19 129
NAMENDA 399 395 20 47
ATORVASTATIN CALCIUM 391 359 21 9
DONEPEZIL HCL 363 363 22 28
CITALOPRAM HBR 353 314 23 31
PRAVASTATIN SODIUM 352 289 24 23
ZOLPIDEM TARTRATE 329 273 25 17
CLOPIDOGREL 307 285 26 26
PREDNISONE 307 253 26 52
POLYETHYLENE GLYCOL 3350 281 257 28 74
SPIRIVA 277 249 29 54
DIOVAN 265 238 30 19
ISOSORBIDE MONONITRATE ER 263 243 31 44
RANITIDINE HCL 246 224 32 36
PANTOPRAZOLE SODIUM 239 229 33 61
DIGOXIN 239 238 33 56
LOVASTATIN 238 212 35 46
SERTRALINE HCL 227 195 36 30
PLAVIX 223 195 37 29
TRAMADOL HCL 214 132 38 40
JANUVIA 202 183 39 25
TAMSULOSIN HCL 202 195 39 20
RISPERIDONE 200 198 41 78
LOSARTAN POTASSIUM 196 162 42 14
NYSTATIN-TRIAMCINOLONE 195 177 43 142
GABAPENTIN 192 148 44 21
HYDROCHLOROTHIAZIDE 185 163 45 10
MELOXICAM 173 138 46 53
FLUTICASONE PROPIONATE 162 128 47 38
AZITHROMYCIN 160 132 48 42
ZETIA 157 135 49 68
SINGULAIR 156 128 50 62
ADVAIR DISKUS 154 113 51 32
FENTANYL 152 116 S2 52 172
GLIMEPIRIDE 150 147 53 37
EXELON 145 140 54 162
ESCITALOPRAM OXALATE 144 129 55 89
NEXIUM 137 126 56 16
CLONIDINE HCL 136 106 57 79
LEVETIRACETAM 133 117 58 92
DILTIAZEM 24HR ER 133 116 58 136
FENOFIBRATE 133 110 58 102
MIRTAZAPINE 131 124 61 45
METOCLOPRAMIDE HCL 127 99 62 176
LEVOFLOXACIN 127 102 62 109
DILTIAZEM ER 127 122 62 277
ALLOPURINOL 118 101 65 41
PROAIR HFA 118 88 65 60
TRIAMTERENE-HCTZ 115 106 67 86
NIASPAN 115 113 67 175
OXYBUTYNIN CHLORIDE 112 92 69 227
NATEGLINIDE 104 85 70 272
SYNTHROID 102 90 71 33
HYDRALAZINE HCL 102 85 71 73
OLANZAPINE 101 81 73 140
ACTOS 101 92 73 85
COMBIVENT 101 73 73 156
CEFUROXIME 101 94 73 273
LEVOXYL 100 76 77 238
DOXYCYCLINE HYCLATE 99 83 78 247
MONTELUKAST SODIUM 99 82 78 123
OXYBUTYNIN CHLORIDE ER 97 90 80 204
PAROXETINE HCL 94 74 81 93
LOVAZA 91 59 82 43
CIPROFLOXACIN HCL 91 77 82 84
INSULIN SYRINGE 87 66 84 137
CEPHALEXIN 86 77 85 189
CARVEDILOL 86 82 85 24
MECLIZINE HCL 85 66 87 81
CELEBREX 85 73 87 80
BUSPIRONE HCL 85 70 87 183
CARAFATE 84 82 90 395
KLOR-CON M10 84 81 90 248
PEN NEEDLE 83 70 92 144
VENLAFAXINE HCL ER 83 79 92 186
CYMBALTA 82 58 94 90
ACTONEL 82 82 94 134
AMOX TR-POTASSIUM CLAVULANATE 81 58 96 141
LIPITOR 80 72 97 51
JANUMET 79 51 98 77
NITROFURANTOIN MONO-MACRO 78 74 99 350
QUETIAPINE FUMARATE 78 70 99 75
TRAZODONE HCL 77 40 101 71
RIVASTIGMINE 77 77 101 364
AGGRENOX 76 74 103 235
CYCLOBENZAPRINE HCL 76 51 R 103 143
HUMALOG 75 66 105 245
SUCRALFATE 74 54 106 303
BENAZEPRIL HCL 74 67 106 131
LANSOPRAZOLE 73 51 108 113
DIOVAN HCT 72 69 109 39
VESICARE 71 59 110 210
PROPRANOLOL HCL 71 66 110 199
ZOSTAVAX 71 69 110 219
SYMBICORT 69 54 113 120
ULTICARE 68 61 114 573
RAMIPRIL 67 45 115 50
CILOSTAZOL 66 55 116 206
NYSTATIN 65 54 117 168
QUINAPRIL HCL 64 61 118 82
HYDROXYCHLOROQUINE SULFATE 63 53 119 285
LEVOCETIRIZINE DIHYDROCHLORIDE 63 45 119 364
VYTORIN 63 62 119 152
AMITRIPTYLINE HCL 63 48 R 119 177
CARBIDOPA-LEVODOPA 62 61 123 98
EVISTA 62 62 123 65
LANTUS 61 43 125 66
ROPINIROLE HCL 60 45 126 208
LOSARTAN-HYDROCHLOROTHIAZIDE 59 56 127 35
NOVOLOG MIX 70-30 58 54 128 346
ALPRAZOLAM 57 39 129 259
NAPROXEN 55 36 130 95
VENTOLIN HFA 55 41 130 64
FELODIPINE ER 54 54 132 128
JANTOVEN 54 54 132 106
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 54 132 49
SPIRONOLACTONE 53 48 135 88
GLYBURIDE 52 47 R 136 67
OXYCODONE HCL 51 28 S2 137 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.